/R E P E A T -- VIDEO B-ROLL AVAILABLE VIA CNW - A Safe and Effective Drug
for Morning Sickness- A Large New American Study Reports/
MONTREAL, Sept. 16 /CNW/ - The following B-Roll is available by Video On-Demand web download:
STORY SUMMARY: In the latest issue of the American Journal of Obstetrics and Gynecology, a group of American and Canadian researchers report on the effectiveness of Diclectin® (the delayed-release formulation of doxylamine and vitamin B6) for morning sickness.
The study, conducted as part of the FDA submission for Diclectin, was carried out in 3 university centers in the US: University of Pittsburgh, Texas (Galveston), and Georgetown (Washington DC). All three centers belong to the National Institute of Child and Human Development from the Obstetric Pharmacology Unit Network.
Morning sickness affects 80% of pregnant women, and many of them need relief from their symptoms to be able to function at home and at work.
WEB Video Preview and Download link:
http://cnw.pathfireondemand.com/viewpackage.action?packageid=387
TIME OF POSTING: | available now |
DATE OF POSTING: | September 16, 2010 |
All video can be viewed by clicking on the link. Broadcast quality video is available for download by accredited journalists. Please contact [email protected] for access.
STATIONS, FOR FURTHER INFORMATION, PLEASE CALL:
Christine Walter: [email protected] 1 877 833-7734 cell. 514 895-8798
Dr. G. Koren: 416 813-5781 (Niki Balamatsis)
Gary D.V. Hankins, MD: 409 772-1957 .
For assistance with Video On-Demand, please contact CNW at [email protected] or (416) 863-2115.
CNW Video On-Demand http://cnw.pathfireondemand.com provides free, secure and easy-to-use broadcast quality material direct from our website to accredited journalists worldwide.
This material is offered for free and unrestricted news use.
CNW VIDEO SERVICES.
For further information:
CNW VIDEO SERVICES, TORONTO (416) 863-2115
Share this article